| Product Code: ETC13117519 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In the Indonesia pneumococcal vaccines market, the import trend experienced a decline from 2023 to 2024, with a growth rate of -22.27%. The compound annual growth rate (CAGR) for imports from 2020 to 2024 stood at -23.29%. This negative momentum can be attributed to shifting demand dynamics or regulatory changes impacting trade flows.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Pneumococcal Vaccines Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Pneumococcal Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Indonesia Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Indonesia Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Indonesia Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Indonesia Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2022 & 2032F |
3.7 Indonesia Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.8 Indonesia Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Indonesia Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Indonesia |
4.2.2 Government initiatives to improve healthcare infrastructure and increase vaccination coverage |
4.2.3 Growing prevalence of pneumococcal diseases in Indonesia |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to healthcare services in rural areas of Indonesia |
4.3.3 Lack of comprehensive vaccination programs in certain regions |
5 Indonesia Pneumococcal Vaccines Market Trends |
6 Indonesia Pneumococcal Vaccines Market, By Types |
6.1 Indonesia Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2022 - 2032F |
6.1.4 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2022 - 2032F |
6.1.5 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2022 - 2032F |
6.1.6 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2022 - 2032F |
6.1.7 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Indonesia Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2022 - 2032F |
6.2.3 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2022 - 2032F |
6.2.4 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2022 - 2032F |
6.2.5 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2022 - 2032F |
6.2.6 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Indonesia Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.3.4 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Government, 2022 - 2032F |
6.3.5 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2022 - 2032F |
6.3.6 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Indonesia Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2022 - 2032F |
6.4.3 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2022 - 2032F |
6.4.4 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2022 - 2032F |
6.4.5 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2022 - 2032F |
6.4.6 Indonesia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
7 Indonesia Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Indonesia Pneumococcal Vaccines Market Export to Major Countries |
7.2 Indonesia Pneumococcal Vaccines Market Imports from Major Countries |
8 Indonesia Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Percentage of children vaccinated with pneumococcal vaccines |
8.2 Number of healthcare facilities offering pneumococcal vaccines |
8.3 Research and development investment in new pneumococcal vaccine technologies |
9 Indonesia Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Indonesia Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Indonesia Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2022 & 2032F |
9.3 Indonesia Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2022 & 2032F |
9.4 Indonesia Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Indonesia Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Indonesia Pneumococcal Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Indonesia Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here